期刊
EUROPEAN JOURNAL OF IMMUNOLOGY
卷 38, 期 11, 页码 2964-2968出版社
WILEY-BLACKWELL
DOI: 10.1002/eji.200838764
关键词
Cancer; Immunosurveillance; NK cells; Therapy
类别
资金
- National Health and Medical Research Council (NHMRC) of Australia
- Leukaemia Foundation of Australia for a Research Scholarship
- Doherty Fellowship
Our current knowledge of NK-cell recognition and effector function suggests that it will be possible to design various new NK-cell-based immunotherapies against human cancer. The application of NK cells is already showing promise using HLA-mismatched haematopoietic stem cell transplantation for treatment of haematological malignancies. A better understanding of NK-cell heterogeneity and function will only broaden the applications for human cancer. Here we review the key developments that will propel this field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据